John Greenman,
Professor of Tumour Immunology,
The University Of Hull
John Greenman is a tumour immunologist with extensive experience of developing lab on a chip technology for analysing tumour biopsies. He has published 148 peer-reviewed publications and his immunobiology group works closely with clinicians, chemists and engineers. The majority of this research work has focused on tumours of the Head & Neck region, identifying novel markers of progression or treatment response. Funding has come from the Research Councils (EPSRC, BBSRC, NC3Rs) Innovate/EPSRC UK, NIHR, EU FP7, Heart Research UK and Yorkshire Cancer Research.
|
|
Microfluidic Chips and Cancer TreatmentWednesday, 6 April 2016 at 09:30 Add to Calendar ▼2016-04-05 08:58:002016-04-05 09:58:00Europe/LondonSession Title: Why are Organs-on-Chip Attractive Proxies for Drug Discovery and Toxicity Screening?Organ-on-a-Chip Europe 2016 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.comThe interdisciplinary lab on a chip group at the University of Hull have been characterizing and optimizing devices that can maintain fresh tissue biopsies in a functional state. This tissue can then be subjected to various “treatments” and the effects measured through analysis of the supernatant or post-treatment tissue. Results from varied tumour types and analyses will be presented.
|